Log in to save to my catalogue

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkp...

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkp...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_721f0d0be9e345b393f57f040b3f9b1c

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Recent evidence suggested a potential correlation between overweight and the efficacy of immune checkpoint inhibitors (ICIs) in cancer patients.
We conducted a retrospective study of advanced cancer patients consecutively treated with anti-PD-1/PD-L1 inhibitors, in order to compare clinical outcomes according to baseline BMI levels as primary an...

Alternative Titles

Full title

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_721f0d0be9e345b393f57f040b3f9b1c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_721f0d0be9e345b393f57f040b3f9b1c

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/s40425-019-0527-y

How to access this item